AILBRY - Article Search
Serach over 250 million academic articles from all areas of study
Results for 'Selumetinib'
:
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
Publication Year: 2013
DOI: https://doi.org/10.1056/nejmoa1209288
Abstract:
Add to Library
Authors:
Alan L. Ho
Ravinder K. Grewal
Rébecca Leboeuf
Eric J. Sherman
David G. Pfister
Désirèe Deandreis
Keith S. Pentlow
Pat Zanzonico
Sofia Haque
Somali Gavane
Ronald Ghossein
Julio C. Ricarte-Filho
José Miguel Domínguez
Ronglai Shen
R. Michael Tuttle
Steven M. Larson
James A. Fagin
Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma
Publication Year: 2014
DOI: https://doi.org/10.1001/jama.2014.6096
Abstract:
Add to Library
Authors:
Richard D. Carvajal
Jeffrey A. Sosman
J. Fernando Quevedo
Mohammed Milhem
Anthony M. Joshua
Ragini R. Kudchadkar
Gerald P. Linette
Thomas F. Gajewski
Jose Lutzky
David H. Lawson
Christoph Höeller
Patrick J. Flynn
Mark R. Albertini
Takami Sato
Karl D. Lewis
Austin Doyle
Kristin Kathleen Ancell
Katherine S. Panageas
Mark J. Bluth
Cyrus V. Hedvat
Joseph P. Erinjeri
Grazia Ambrosini
Brian P. Marr
David H. Abramson
Mark A. Dickson
Jedd D. Wolchok
Paul B. Chapman
Gary K. Schwartz
Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas
Publication Year: 2016
DOI: https://doi.org/10.1056/nejmoa1605943
Abstract:
Add to Library
Authors:
Eva Dombi
Andrea Baldwin
Leigh Marcus
Michael J. Fisher
Brian Weiss
AeRang Kim
Patricia Whitcomb
Staci Martin
Lindsey Aschbacher‐Smith
Tilat A. Rizvi
Jianqiang Wu
Rachel Ershler
Pamela L. Wolters
Janet Therrien
John Glod
Jean B. Belasco
Elizabeth K. Schorry
Alessandra Brofferio
Amy J. Starosta
Andrea Gillespie
Austin L. Doyle
Nancy Ratner
Brigitte C. Widemann
Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study
Publication Year: 2013
DOI: https://doi.org/10.1016/s1470-2045(12)70489-8
Abstract:
Add to Library
Authors:
Pasi A. Jänne
Alice T. Shaw
Judith Balmañà
G. Jeannin
Johan Vansteenkiste
Carlos H. Barrios
Fábio Franke
Lynda Grinsted
Victoria Zazulina
Paul D. Smith
Ian C. P. Smith
Lucio Crinò
Selumetinib in Children with Inoperable Plexiform Neurofibromas
Publication Year: 2020
DOI: https://doi.org/10.1056/nejmoa1912735
Abstract:
Add to Library
Authors:
Andrea M. Gross
Pamela L. Wolters
Eva Dombi
Andrea Baldwin
Patricia Whitcomb
Michael J. Fisher
Brian Weiss
AeRang Kim
Miriam Bornhorst
Amish C. Shah
Staci Martin
Marie Claire Roderick
Dominique C. Pichard
Amanda Carbonell
Scott M. Paul
Janet Therrien
Oxana B. Kapustina
Kara Heisey
D. Wade Clapp
Chi Zhang
Cody J. Peer
William D. Figg
Malcolm A. Smith
John Glod
Jaishri O. Blakeley
Seth M. Steinberg
David Venzon
L. Austin Doyle
Brigitte C. Widemann
Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers
Publication Year: 2011
DOI: https://doi.org/10.1200/jco.2010.33.9473
Abstract:
Add to Library
Authors:
Tanios Bekaii‐Saab
Mitch A. Phelps
Xiaobai Li
Motoyasu Saji
Laura W. Goff
John S. Kauh
Bert H. O’Neil
Stephanie Balsom
Catherine Balint
R. Liersemann
Vasily Vasko
Mark Bloomston
W. Marsh
L. Austin Doyle
Gilian Ellison
Michael R. Grever
Matthew D. Ringel
Miguel A. Villalona‐Calero
Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)
Publication Year: 2010
DOI: https://doi.org/10.1158/0008-5472.can-09-1577
Abstract:
Add to Library
Authors:
Jonathan R. Dry
Sandra Pavey
Christine A. Pratilas
Chris Harbron
Sarah Runswick
Darren Hodgson
Christine M. Chresta
Rose McCormack
Natalie Byrne
Mark Cockerill
Alexander Graham
Garry Beran
Andrew Cassidy
Carolyn Haggerty
Helen Brown
Gillian Ellison
Judy Dering
Barry S. Taylor
Mitchell Stark
Vanessa Bonazzi
Sugandha Ravishankar
Leisl Packer
Feng Xing
David B. Solit
Richard S. Finn
Neal Rosen
Nicholas K. Hayward
Tim French
Paul D. Smith
Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
Publication Year: 2012
DOI: https://doi.org/10.1016/s1470-2045(12)70572-7
Abstract:
Add to Library
Authors:
John Farley
William E. Brady
Vinod Vathipadiekal
Heather A. Lankes
Robert L. Coleman
Mark A. Morgan
Robert S. Mannel
S. Diane Yamada
David G. Mutch
William H. Rodgers
Michael J. Birrer
David M. Gershenson
Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
Publication Year: 2013
DOI: https://doi.org/10.1016/s1470-2045(12)70572-7
Abstract:
Add to Library
Authors:
John Farley
William E. Brady
Vinod Vathipadiekal
Heather A. Lankes
Robert L. Coleman
Mark A. Morgan
Robert S. Mannel
S. Diane Yamada
David G. Mutch
William H. Rodgers
Michael J. Birrer
David M. Gershenson
TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer
Publication Year: 2020
DOI: https://doi.org/10.1016/j.annonc.2020.01.013
Abstract:
Add to Library
Authors:
Geoffrey R. Oxnard
J.C.-H. Yang
Helena A. Yu
Seung‐Whan Kim
Hideo Saka
Leora Horn
Kōichi Goto
Yuichiro Ohe
Helen Mann
Kenneth S. Thress
Melanie M. Frigault
Karthick Vishwanathan
Dana Ghiorghiu
Suresh S. Ramalingam
Myung‐Ju Ahn
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)
Publication Year: 2018
DOI: https://doi.org/10.1200/jco.2017.74.1090
Abstract:
Add to Library
Authors:
Richard D. Carvajal
Sophie Piperno‐Neumann
Ellen Kapiteijn
Paul B. Chapman
Stephen Jay Frank
Anthony M. Joshua
Josep M. Piulats
Pascal Wolter
Véronique Cocquyt
Bartosz Chmielowski
T.R. Jeffry Evans
Lauris Gastaud
Gerald P. Linette
Carola Berking
Jacob Schachter
Manuel Rodrigues
Alexander N. Shoushtari
Delyth Clemett
Dana Ghiorghiu
C Mereu
Shirley Spratt
Susan Lovick
Peter Barker
Elaine Kilgour
Zhongwu Lai
Gary K. Schwartz
Paul Nathan
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial
Publication Year: 2019
DOI: https://doi.org/10.1016/s1470-2045(19)30277-3
Abstract:
Add to Library
Authors:
Jason Fangusaro
Arzu Onar‐Thomas
Tina Young Poussaint
Shengjie Wu
Azra H. Ligon
Neal I. Lindeman
Anuradha Banerjee
Roger J. Packer
Lindsay Kilburn
Stewart Goldman
Ian F. Pollack
Ibrahim Qaddoumi
Regina I. Jakacki
Paul G. Fisher
Girish Dhall
Patricia Baxter
Susan G. Kreissman
Clinton F. Stewart
David Jones
Stefan M. Pfister
Gilbert Vézina
Jessica Stern
Ashok Panigrahy
Zoltán Patay
Benita Tamrazi
Jeremy Jones
Sofia Haque
David S. Enterline
Soonmee Cha
Michael J. Fisher
L. Austin Doyle
Malcolm A. Smith
Ira J. Dunkel
Maryam Fouladi
Phase II, Open-Label, Randomized Trial of the MEK1/2 Inhibitor Selumetinib as Monotherapy versus Temozolomide in Patients with Advanced Melanoma
Publication Year: 2012
DOI: https://doi.org/10.1158/1078-0432.ccr-11-1491
Abstract:
Add to Library
Authors:
John M. Kirkwood
Lars Bastholt
Caroline Robert
Jeff Sosman
James Larkin
Peter Hersey
Mark R. Middleton
Mireille Cantarini
Victoria Zazulina
Karin Kemsley
Reinhard Dummer
Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With <i>KRAS</i>-Mutant Advanced Non–Small Cell Lung Cancer
Publication Year: 2017
DOI: https://doi.org/10.1001/jama.2017.3438
Abstract:
Add to Library
Authors:
Pasi A. Jänne
Michel M. van den Heuvel
Fabrice Barlési
Manuel Cobo
Julien Mazières
Lucio Crinò
С. В. Орлов
Fiona Blackhall
Juergen Wolf
Pilar Garrido
Artem Poltoratskiy
C Mereu
Dana Ghiorghiu
Elaine Kilgour
Paul D. Smith
Alexander Kohlmann
David Carlile
David Lawrence
Karin Bowen
Johan Vansteenkiste
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
Publication Year: 2017
DOI: https://doi.org/10.1093/neuonc/now282
Abstract:
Add to Library
Authors:
Anuradha Banerjee
Regina I. Jakacki
Arzu Onar‐Thomas
Shengjie Wu
Theodore Nicolaides
Tina Young Poussaint
Jason Fangusaro
Joanna J. Phillips
Arie Perry
David C. Turner
Michael D. Prados
Roger J. Packer
Ibrahim Qaddoumi
Sridharan Gururangan
Ian F. Pollack
Stewart Goldman
L. Austin Doyle
Clinton F. Stewart
James M. Boyett
Larry E. Kun
Maryam Fouladi
Found 6569 results in 0.09 seconds
What is Boolean Searches
Including any of the words AND
, OR
, or NOT
in any of your searches will enable
boolean search. Those words must be UPPERCASE . You can use this in all searches, including using
the search parameter, and using search filters.
This allows you to craft complex queries using those boolean operators along with parentheses and quotation marks.
Surrounding a phrase with quotation marks will search for an exact match of that phrase, after stemming and
stop-word removal (be sure to use double quotation marks — "
). Using parentheses will specify order of
operations for the boolean operators. Words that are not separated by one of the boolean operators will be
interpreted as AND
.
Behind the scenes, the boolean search is using Elasticsearch's query string query on the searchable fields (such as
title, abstract, and fulltext for works; see each individual entity page for specifics about that entity). Wildcard
and fuzzy searches using *
, ?
or ~
are not allowed; these characters will be
removed from any searches. These searches, even when using quotation marks, will go through the same cleaning as
described above, including stemming and removal of stop words.
Example Search
Search for works that mention "elmo"
and "sesame street"
, but not the words
"cookie"
or "monster"
:
"elmo" AND "sesame street" NOT "cookie" NOT "monster"